The on-treatment intratumoral accumulation of CD8 + T cells with memory-like features has been associated with enhanced cytotoxicity [128] and stands as a correlate of response to PD-1 blockade in preclinical models as well as in clinical studies [97, 129], suggesting this to be an important pathway mediating anti-PD-1 tumor control. Here, CD8A is linked to neoplasm.